Cargando…
Role of MicroRNA in Endothelial Dysfunction and Hypertension
PURPOSE OF REVIEW: Hypertension is either a cause or a consequence of the endothelial dysfunction and a major risk factor for cardiovascular disease (CVD). In vitro and in vivo studies established that microRNAs (miRNAs) are decisive for endothelial cell gene expression and function in various patho...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102349/ https://www.ncbi.nlm.nih.gov/pubmed/27837398 http://dx.doi.org/10.1007/s11906-016-0696-8 |
_version_ | 1783511805470965760 |
---|---|
author | Nemecz, Miruna Alexandru, Nicoleta Tanko, Gabriela Georgescu, Adriana |
author_facet | Nemecz, Miruna Alexandru, Nicoleta Tanko, Gabriela Georgescu, Adriana |
author_sort | Nemecz, Miruna |
collection | PubMed |
description | PURPOSE OF REVIEW: Hypertension is either a cause or a consequence of the endothelial dysfunction and a major risk factor for cardiovascular disease (CVD). In vitro and in vivo studies established that microRNAs (miRNAs) are decisive for endothelial cell gene expression and function in various pathological conditions associated with CVD. This review provides an overview of the miRNA role in controlling the key connections between endothelial dysfunction and hypertension. RECENT FINDINGS: Herein we summarize the present understanding of mechanisms underlying hypertension and its associated endothelial dysfunction as well as the miRNA role in endothelial cells with accent on the modulation of renin-angiotensin-aldosterone-system, nitric oxide, oxidative stress and on the control of vascular inflammation and angiogenesis in relation to endothelial dysfunction in hypertension. In particular, latest insights in the identification of endothelial-specific microRNAs and their targets are added to the understanding of miRNA significance in hypertension. SUMMARY: This comprehensive knowledge of the role of miRNAs in endothelial dysfunction and hypertension and of molecular mechanisms proposed for miRNA actions may offer novel diagnostic biomarkers and therapeutic targets for controlling hypertension-associated endothelial dysfunction and other cardiovascular complications. |
format | Online Article Text |
id | pubmed-7102349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-71023492020-03-31 Role of MicroRNA in Endothelial Dysfunction and Hypertension Nemecz, Miruna Alexandru, Nicoleta Tanko, Gabriela Georgescu, Adriana Curr Hypertens Rep Hypertension and Metabolic Syndrome (J Sperati, Section Editor) PURPOSE OF REVIEW: Hypertension is either a cause or a consequence of the endothelial dysfunction and a major risk factor for cardiovascular disease (CVD). In vitro and in vivo studies established that microRNAs (miRNAs) are decisive for endothelial cell gene expression and function in various pathological conditions associated with CVD. This review provides an overview of the miRNA role in controlling the key connections between endothelial dysfunction and hypertension. RECENT FINDINGS: Herein we summarize the present understanding of mechanisms underlying hypertension and its associated endothelial dysfunction as well as the miRNA role in endothelial cells with accent on the modulation of renin-angiotensin-aldosterone-system, nitric oxide, oxidative stress and on the control of vascular inflammation and angiogenesis in relation to endothelial dysfunction in hypertension. In particular, latest insights in the identification of endothelial-specific microRNAs and their targets are added to the understanding of miRNA significance in hypertension. SUMMARY: This comprehensive knowledge of the role of miRNAs in endothelial dysfunction and hypertension and of molecular mechanisms proposed for miRNA actions may offer novel diagnostic biomarkers and therapeutic targets for controlling hypertension-associated endothelial dysfunction and other cardiovascular complications. Springer US 2016-11-11 2016 /pmc/articles/PMC7102349/ /pubmed/27837398 http://dx.doi.org/10.1007/s11906-016-0696-8 Text en © Springer Science+Business Media New York 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Hypertension and Metabolic Syndrome (J Sperati, Section Editor) Nemecz, Miruna Alexandru, Nicoleta Tanko, Gabriela Georgescu, Adriana Role of MicroRNA in Endothelial Dysfunction and Hypertension |
title | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
title_full | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
title_fullStr | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
title_full_unstemmed | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
title_short | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
title_sort | role of microrna in endothelial dysfunction and hypertension |
topic | Hypertension and Metabolic Syndrome (J Sperati, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102349/ https://www.ncbi.nlm.nih.gov/pubmed/27837398 http://dx.doi.org/10.1007/s11906-016-0696-8 |
work_keys_str_mv | AT nemeczmiruna roleofmicrornainendothelialdysfunctionandhypertension AT alexandrunicoleta roleofmicrornainendothelialdysfunctionandhypertension AT tankogabriela roleofmicrornainendothelialdysfunctionandhypertension AT georgescuadriana roleofmicrornainendothelialdysfunctionandhypertension |